Name | Symbol | Markt | Aktientyp |
---|---|---|---|
InVivo Therapeutics Holdings Corporation | NVIV | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
0,3207 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
21.3.2024 | 19:23 | EDGAR2 | Form 25-NSE - Notification filed by national security.. |
14.2.2024 | 20:53 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
14.2.2024 | 02:09 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
07.2.2024 | 20:12 | EDGAR2 | Form 4/A - Statement of changes in beneficial ownership of.. |
07.2.2024 | 19:31 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
06.2.2024 | 18:08 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
06.2.2024 | 14:00 | EDGAR2 | Form 8-K - Current report |
01.2.2024 | 14:00 | EDGAR2 | Form 8-K - Current report |
05.12.2023 | 14:30 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
01.12.2023 | 22:30 | EDGAR2 | Form 8-K - Current report |
30.11.2023 | 16:31 | EDGAR2 | Form 8-K - Current report |
08.11.2023 | 22:31 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
01.9.2023 | 22:30 | EDGAR2 | Form 8-K - Current report |
09.8.2023 | 22:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |